Disclosures for "A Case of Paraneoplastic Trigeminal Neuropathy in the Setting of Renal Cell Carcinoma"
-
Dr. Dunn has nothing to disclose.
-
Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.